BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30632215)

  • 21. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation.
    Brand HS; Bots CP; Raber-Durlacher JE
    Br Dent J; 2009 Nov; 207(9):E17; discussion 428-9. PubMed ID: 19893563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.
    Markowski J; Helbig G; Widziszowska A; Likus W; Kyrcz-Krzemień S; Jarosz U; Dziubdziela W; Markiewicz M
    Med Sci Monit; 2015 Apr; 21():1173-80. PubMed ID: 25907308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis.
    Rabian F; Porcher R; Sicre de Fontbrune F; Lioure B; Laplace A; Nguyen S; Tabrizi R; Vigouroux S; Tomowiak C; Maillard N; Suarez F; Delage J; Peffault de Latour R; Socié G;
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1721-1724. PubMed ID: 27246370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
    Fan WC; Liu CJ; Hong YC; Feng JY; Su WJ; Chien SH; Chen TJ; Chiang CH
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):58-64. PubMed ID: 25519791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients.
    Correia-Silva Jde F; Victória JM; Guimarães AL; Salomão UE; de Abreu MH; Bittencourt H; Gomez RS
    Oral Dis; 2007 Mar; 13(2):163-9. PubMed ID: 17305617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
    Kashyap A; Wingard J; Cagnoni P; Roy J; Tarantolo S; Hu W; Blume K; Niland J; Palmer JM; Vaughan W; Fernandez H; Champlin R; Forman S; Andersson BS
    Biol Blood Marrow Transplant; 2002; 8(9):493-500. PubMed ID: 12374454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
    Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
    Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea.
    Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB
    J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation.
    Uchino M; Ogawa Y; Uchino Y; Mori T; Okamoto S; Tsubota K
    Br J Ophthalmol; 2012 Jan; 96(1):34-7. PubMed ID: 22053104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.
    El-Ghammaz AMS; Ben Matoug R; Elzimaity M; Mostafa N
    Support Care Cancer; 2017 Oct; 25(10):3085-3093. PubMed ID: 28439725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
    Junghanss C; Marr KA; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Chauncey T; McSweeney PA; Storb R
    Biol Blood Marrow Transplant; 2002; 8(9):512-20. PubMed ID: 12374456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    Support Care Cancer; 2007 May; 15(5):491-6. PubMed ID: 17139495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) changes in inorganic salivary components.
    Boer CC; Correa ME; Tenuta LM; Souza CA; Vigorito AC
    Support Care Cancer; 2015 Sep; 23(9):2561-7. PubMed ID: 25652148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.